AN
Anixa Biosciences, Inc.
ANIX · NASDAQ
$2.76 -3.83% (-$0.11)
1M -20.92%
Market Cap $93.9M
P/E Ratio -
Div. Yield -
ROE 52.83%
Bulios Fair Price
$1.51
45.3% downside
Trenutna cena
$2.76
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ANIX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
19 /100
Expensive P/B 6.49x
P/FCF N/A
P/S N/A
Growth
0 /100
Declining Book val. growth 19.49%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
0 /100
Poor Asset turnover 0.00x
ROA 51.85%
ROIC 82.06%
Debt
100 /100
Low Current ratio 8.54x
Debt/Equity 0.01x
Net debt/EBITDA N/A
Stability
68 /100
Stable EPS volatility 25.95%
Profitable years 0
Beta 0.60x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ANIX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Amit Kumar
Employees
4
Headquarters
San Jose
Prihajajoči dogodki
11 JAN.
Earnings
Upcoming earnings report